PETQ PetIQ Inc. Class A

PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support Resources

PetIQ, Inc. Kicks Off Flea & Tick Season With NextStar® Campaign Introducing New Pet Parent Education and Veterinary Support Resources

Vet-Recommended NextStar® “Kills, Protects, Prevents” Without a Prescription; Telehealth Support Line with Real-Time, Live Veterinary Professionals Available for Pet Parents

EAGLE, Idaho, March 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, has officially kicked off flea & tick season with NextStar,® the fastest-acting 30-day topical protection available,* to help educate pet parents on year-round monthly prevention to get ahead of seasonal upticks in infestations and keep pets and the moments pet parents share with them protected.

Available at local retailers and online with no prescription needed, NextStar’s® veterinarian-recommended** formula not only kills fleas and ticks; it also kills mosquitoes, chewing lice, flea eggs, flea larvae, and prevents the development of flea pupae with its 7-way pest protection. The waterproof topical is easy to use and can be applied directly onto pets’ skin for protection that kills fleas and ticks through contact and starts working within minutes, all month long. When applying NextStar® for the first time or after a lapse in monthly prevention, full nose-to-tail protection is in place 24-48 hours after initial application.

With flea and tick season quickly approaching in early Spring, NextStar® is offering an extra measure of peace of mind beyond monthly protection with a new telehealth support line, the first of its kind for any flea and tick preventive. Available 24 hours a day, 7 days a week, the telehealth line, provides real-time support from veterinary telehealth specialists to address parasite-related concerns, questions, and prevention or infestation education for NextStar® customers (with proof of purchase).

“Every moment we share with our pets deserves protecting, especially against fleas and ticks, which can pose a dangerous threat to pets by carrying diseases or causing serious skin reactions,” said John Pearson, PetIQ’s Executive Vice President, Services and Manufactured Products. “NextStar® preserves those special moments with our pets with its fast-acting formula that can be applied monthly for year-round protection, helping pet parents feel more at ease knowing that their pet is pest-free, healthy, and happy.”





NextStar,® a PetIQ brand, is available at Walmart, Amazon, Target, and Tractor Supply Company, as well as PetIQ’s vast network of preventive care community clinics and wellness centers across the nation. Visit the to start your flea and tick prevention for and . Pet weight - small dogs 5-22 lbs, medium dogs 23 - 44 lbs, large dogs 45 - 88 lbs, and XL dogs weighing 89 - 138 lbs.

*The fastest-acting comparison for dog formula only, based on label claims for NextStar® flea and tick topical for dogs, and other leading dog topical brands. Data on file.

**Data on file.

About PetIQ:

PetIQ is a leading pet medication, product and wellness company delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable health and wellness products and veterinary services. The Company's product business engages with pet parents through retail and e-commerce channels in more than 60,000 points of distribution with its branded and distributed pet medications as well as health and wellness items, which are further supported by its world-class medications manufacturing facility in Omaha, Nebraska and health and wellness manufacturing facility in Springville, Utah. The Company’s veterinarian service platform operates in over 2,600 community clinic locations and wellness centers hosted at retailers in 39 states providing cost effective and convenient veterinary wellness services. PetIQ believes that pets are an important part of the family and deserve the best products and care we can provide.

PR Contacts:

PetIQ Corporate: or 407.929.6727

PetIQ Consumer: or 917.660.6359

A photo accompanying this announcement is available at



EN
07/03/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetIQ Inc. Class A

 PRESS RELEASE

PetIQ Names Camillo Pane as Chief Executive Officer

PetIQ Names Camillo Pane as Chief Executive Officer Accomplished Consumer Goods and Health Care LeaderWould Bring Decades of Leadership Experience to Role EAGLE, Idaho, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”), a leading pet medication, health and wellness company and portfolio company of Bansk Group, is pleased to announce that Camillo Pane would join PetIQ as Chief Executive Officer, effective February 17, 2025. Mr. Pane would succeed Cord Christensen. Mr. Pane’s passion for making a difference in the lives of consumers has been a constant focus through...

 PRESS RELEASE

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Gr...

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion. PetIQ stockholders will receive $31.00 in cash per PetIQ share in accordance with the terms of the tran...

 PRESS RELEASE

PetIQ, Inc. Announces Results of Special Meeting of Stockholders

PetIQ, Inc. Announces Results of Special Meeting of Stockholders Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 EAGLE, Idaho, Oct. 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, announced today that at its virtual Special Meeting of Stockholders approximately 80% of its outstanding shares of common stock voted to approve the adoption of the definitive merger agreement (the “Agreement”) pursuant to which Bansk Group will acquir...

 PRESS RELEASE

PetIQ, Inc. Reports Second Quarter 2024 Financial Results

PetIQ, Inc. Reports Second Quarter 2024 Financial Results Generates Record Second Quarter 2024 Net Sales and Net IncomeRecord Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 GuidancePetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the second quarter and six months ended June 30, 2024. Cord Christensen, PetIQ’s Founder and CEO, commented, “We are ...

 PRESS RELEASE

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk G...

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion EAGLE, Idaho, and NEW YORK, New York, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, today announced that PetIQ entered into a definitive agreement (the “Agreement”) pursuant to which Bansk...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch